Evaluating home visits for managing chronic conditions like hypertension and diabetes
Assessing the Efficacy of Targeted Home Visits in the Management of Chronic Conditions
This study is testing if home visits from doctors can help people with high blood pressure and diabetes manage their health better than regular clinic visits.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years to 60 Years |
| Sex | All |
| Sponsor | University of Texas Southwestern Medical Center Academic / other |
| Locations | 1 site (Dallas, Texas) |
| Trial ID | NCT05168605 on ClinicalTrials.gov |
What this trial studies
This study aims to assess the effectiveness of home medical visits by Family Medicine physicians in managing hypertension and type 2 diabetes compared to standard clinic visits. Participants will receive two home visits that include comprehensive health assessments and questionnaires to evaluate their health management and experiences. The study will focus on comparing health outcomes between those receiving home visits and those receiving usual care in a clinical setting. Additionally, it seeks to understand the impact of home visits from the patient's perspective.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-60 who speak English or Spanish and have a diagnosis of hypertension or type 2 diabetes.
Not a fit: Patients currently using oral steroids or with a history of solid organ transplant may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could improve health outcomes for patients with chronic conditions by providing more personalized care in their home environment.
How similar studies have performed: Other studies have shown promising results with home visit interventions for chronic disease management, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients ages 18-60 * Spanish or English speaking * Diagnosis of HTN or BP \>140/90 in last 3 months (based on medical record) * Hemoglobin A1C\>8 in last 6 months (based on medical record) * Not pregnant Exclusion Criteria: * Current oral steroid use * History of solid organ transplant * Language other than English or Spanish
Where this trial is running
Dallas, Texas
- UT Southwestern Medical Center — Dallas, Texas, United States (Recruiting)
Study contacts
- Principal investigator: Nora Gimpel, M.D. — University of Texas Southwestern Medical Center
- Study coordinator: Silvia Obregon, MSW
- Email: silvia.obregon@utsouthwestern.edu
- Phone: 214-645-9532
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.